![4-Amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one structure, CAS 405169-16-6](/structures/60000/57076_1_405169_16_6.png)
CAS Number405169-16-6
Synonyms4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one; Dovitinib; 4-Amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one; 4-Amino-5-fluor-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]chinolin-2(1H)-on; Dovitinib (TKI-258,CHIR-258); 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one; Unii-I35H55G906; Dovitinib (TKI-258, CHIR-258); CHIR-258; 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one; 4-amino-5-fluoro-3-[6-(4-methyl-piperazin-1-yl)-1H-benzoimidazol-2-yl]-1H-quinolin-2-one; 4-Amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone; 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H
Molecular FormulaC21H21FN6O
Molecular Weight392.43
Purity≥98 (HPLC)%
Density1.4±0.1 g/cm3
Appearancepowder
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 405169-16-6 |
| Catalog No. | 2A-9057076 |
| Chinese Name | 多韦替尼 |
| Synonyms | 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one; Dovitinib; 4-Amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one; 4-Amino-5-fluor-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]chinolin-2(1H)-on; Dovitinib (TKI-258,CHIR-258); 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one; Unii-I35H55G906; Dovitinib (TKI-258, CHIR-258); CHIR-258; 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one; 4-amino-5-fluoro-3-[6-(4-methyl-piperazin-1-yl)-1H-benzoimidazol-2-yl]-1H-quinolin-2-one; 4-Amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone; 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H |
| Molecular Formula | C21H21FN6O |
| Molecular Weight | 392.43 |
| Purity | ≥98 (HPLC) |
| Density | 1.4±0.1 g/cm3 |
| Appearance | powder |
| Storage Condition | -20°C |
| Application | Dovitinib is a multi-target tyrosine kinase inhibitor with IC50 values of 1, 2, 8/9, 10/13/8, 27/210 nM for inhibiting FLT3, c-Kit, FGFR1/3, VEGFR1/2/3 and PDGFRα/β respectively. |
| MDL Number | MFCD10565680 |
| SMILES | O=C1NC2=C(C(N)=C1C3=NC4=CC=C(N5CCN(CC5)C)C=C4N3)C(F)=CC=C2 |
| InChI | 1S/C21H21FN6O/c1-27-7-9-28(10-8-27)12-5-6-14-16(11-12)25-20(24-14)18-19(23)17-13(22)3-2-4-15(17)26-21(18)29/h2-6,11H,7-10H2,1H3,(H,24,25)(H3,23,26,29) |
| InChI Key | PIQCTGMSNWUMAF-UHFFFAOYSA-N |
| NACRES Code | NA.77 |
| UNSPSC | 12352200 |
| MSDS | msds/57076_1_405169_16_6.pdf |
| Transport Info | Product Name: Dovitinib (TKI-258, CHIR-258) |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| 2-Bromo-6-(trifluoromethoxy)benzoic acid | 403646-46-8 | 2A-9057066 |
| 5-Bromo-2-(trifluoromethoxy)benzoic acid | 403646-47-9 | 2A-9057067 |
| 6-Bromo-1H-indazol-3-amine | 404827-77-6 | 2A-9057069 |
| Panobinostat | 404950-80-7 | 2A-9057073 |
| Besifloxacin hydrochloride | 405165-61-9 | 2A-9057075 |
| 5-Bromo-2-hydroxynicotinonitrile | 405224-22-8 | 2A-9057079 |
| 5-Bromo-2-chloronicotinonitrile | 405224-23-9 | 2A-9057080 |
| Tris[2-(benzo[b]thiophen-2-yl)pyridinato-C3,N]iridium(III) | 405289-74-9 | 2A-9057083 |
| 3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid | 405518-55-0 | 2A-9057084 |
| 4-(4,4-Dimethylpiperidin-1-yl)benzoic acid | 406233-26-9 | 2A-9057089 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA